A retrospective analysis of vancomycin pharmacokinetics in Japanese cancer and non-cancer patients based on routine trough monitoring data

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 1, 2009, Pages 99-104

  Omote, Shinobu ^a,b   Yano, Yoshitaka ^c   Hashida, Tohru ^a   Masuda, Satohiro ^a   Yano, Ikuko ^a   Katsura, Toshiya ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b MITSUBISHI KYOTO HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Cancer patient; Malignant; Methicillin resistant Staphylococcus aureus; Pharmacokinetics; Therapeutic drug monitoring; Vancomycin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; CREATININE; VANCOMYCIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BAYES THEOREM; CANCER PATIENT; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MONITORING; FEMALE; FLUID RETENTION; HUMAN; JAPANESE; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; BAYES THEOREM; BLOOD UREA NITROGEN; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; VANCOMYCIN; YOUNG ADULT;

EID: 59949100613     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.99     Document Type: Article

References (29)

1. Sakai C., Satoh Y., Ohkusu K., Kumagai K., Ishii A., J. Jpn. Assoc. Infect. Dis., 75, 940-945 (2001).
2. Fernández de Gatta M., Calvo M. V., Hernández J. M., Caballero D., San Miguel J. F., Domínguez-Gil A., Clin. Pharmacol. Ther., 60, 332-340 (1996).
3. MacGowan A. P., Ther. Drug Monit., 20, 473-477 (1998).
4. Iwamoto T., Kagawa Y., Kojima M., Biol. Pharm. Bull., 26, 876-879 (2003).
5. Leader W. G., Chandler M. H., Clin. Pharmacokinet., 28, 327-342 (1995).
6. Rybak M. J., Clin. Infect. Dis., 42, S35-S39 (2006).
7. Le Normand Y., Milpied N., Kergueris M. F., Harousseau J. L., Int. J. Biomed. Comput., 36, 121-125 (1994).
8. Buelga D. S., Fernandez de Gatta M., Herrera E. V., Dominguez-Gil A., García M. J., Antimicrob. Agents Chemother., 49, 4934-4941 (2005).
9. Aldaz A., Ortega A., Idoate A., Giraldez J., Bougarolas A., Ther. Drug Monit., 22, 250-257 (2000).
10. Fernández de Gatta M., Fruns I., Hernández J. M., Caballero D., San Miguel J. F., Martínez Lanao J., Domínguez-Gil Hurlé A., Clin. Pharm., 12, 515-520 (1993).
11. Yasuhara M., Iga T., Zenda H., Okumura K., Oguma T., Yano Y., Hori R., Ther. Drug. Monit., 20, 139-148 (1998).
12. Jelliffe R. W., Schumitzky A., Bayard D., Milman M., Guilder M. V., Wang X., Jiang F., Barbaut X., Maire P., Clin. Pharmacokinet., 34, 57-77 (1998).
13. Teramachi H., Hatakeyama H., Matsushita R., Imai Y., Miyamoto K., Tsuji A., Biol. Pharm. Bull., 25, 1333-1338 (2002).
14. Ohnishi A., Yano Y., Shimamura K., Oguma T., Biol. Pharm. Bull., 24, 1446-1450 (2001).
15. Matzke G. R., "Applied Pharmacokinetics," 2nd ed., ed. by Evans W. E., Schentag J. J., Jusko W. J., Applied Therapeutics, Inc., Spokane, WA, 1986.
16. Chang D., Lime L., Malogolowkin M., Pediatr. Infect. Dis. J., 13, 969-974 (1994).
17. Krivoy N., Peleg S., Postovsky S., Arush M. W. B., Pediatr. Hematol. Oncol., 15, 333-338 (1998).
18. Chang D., Pediatr. Infect. Dis. J., 14, 667-673 (1995).
19. Teramachi H., Matsushita R., Tsuji A., Jpn. J. Chemother., 53, 357-363 (2005). (in Japanese except Abstract)
20. Cockcroft D. W., Gault M. H., Nephron, 16, 31-41 (1976).
21. Sheiner L. B., Beal S. L., J. Pharm. Sci., 71, 1344-1348 (1982).
22. Yano Y., Oguma T., Jpn. J. Ther. Drug Monit., 14, 179-188 (1997). (in Japanese except Abstract).
23. Sheiner L. B., Beal S. L., J. Pharmacokinet. Biopharm., 9, 503-512 (1981).
24. Tsuchiwata S., Mihara K., Yafune A., Ogata H., Ther. Drug Monit., 27, 18-24 (2005).
25. Mahmood I., Int. J. Clin. Pharmacol. Ther., 41, 392-396 (2003).
26. Ohnishi A., Yano Y., Ishibashi T., Katsube T., Oguma T., Drug Metab. Pharmacokinet., 20, 415-422 (2005).
27. Moellering R. C., Krogstad D. J., Greenblatt D. J., Rev. Infect. Dis., 3S, S230-S235 (1981).
28. Moise-Broder P. A., Forrest A., Birmingham M. C., Schentag J. J., Clin. Pharmacokinet., 43, 925-942 (2004).
29. Igarashi M., Nakatani T., Hayashi M., Nakata K., Kasuya Y., Jpn. J. Chemother., 50, 826-829 (2005). (in Japanese except Abstract)